RE:need evidence based studies which will help their credibilitJust to be clear to any new comers to this board, we have two commercial revenue generating contracts already in the USA & some 24 other proposals out that the company anticipates will have a high rate of acceptance in the very near future. The current SP is just indicative of investors in the summer time with little news other than Matt Julius, the Science Officer, coming on full time. While the SP drifts awaiting signed commercial contracts I have only one question. Why is the SP less than half it was iearlier in the spring ? I believe all investors were looking for contracts to be signed more quickly after several positive results of flowers, MJ & mass/THC increases, vegetable studies and probably one of the most important, the pathogen/mould results. The fact that large LP's will wait for the new HC wording in mid October also contributes to the wait & see mentality. The company is continuing to build and expand its physical, intellectual and human resources to meet current and future demands and investors seem intent on devaluing its worth when in fact it should be gaining acceptance and support. Yes they may need a small raise sometime in the future to pay for inventory and additional staff but that is very positive and encouraging. Personally I'm convinced we are at the cusp of great times for this company & all it has to offer for so many applications - food, MJ/Hemp, outdoor crops, lettuce, flowers, vaccines , UAE, Columbia-PraxAir etc. I talked to Matt during the AGM about getting farmers to buy in to changing their tried and proven current techniques. As he said he just reports on the findings though science and he was very excited. Patience with this one will reward IMO. GLTAL.